Dr. Mikhail Kosiborod, cardiologist and vice president of research at Saint Luke's Health System, joined Medscape InDiscussion to talk about the cardiovascular effects of type 2 diabetes medications.

"As a cardiologist who has been interested in this for so long, I'm looking at the most promising developments for new medications for treating cardiovascular disease, both atherosclerotic cardiovascular disease (ASCVD) and heart failure," Kosiborod said. "And the most promising developments are coming from the field of metabolism."

Listen to or read the Medscape InDiscussion episode: A Brave New World in Type 2 Diabetes Treatment and Beyond

Read more >

Related Content

Apparel, Clothing, Coat, Lab Coat, Person, Doctor
Danielle's story

"You get those rare moments that you're reminded why you went into this field, and it makes everything so much better." Danielle Hammontree, Certified Family Nurse Practitioner, Saint Luke’s East Hospital

Read more >
Person, Doctor, Clothing, Apparel, Lab Coat, Coat, Face, Nurse
Deb's story

Deb Day, Registered Nurse · Anderson County Hospital "I am a Saint Luke's Nurse.  Nurses are the lifeblood of Saint Luke’s compassionate care, and the life-changing work they do is...

Read more >
Person, Hair, Nurse, Face, Female, Word
Nicole's story

"What we do is so vital. We have so much power as nurses." Nicole Roberson, Registered Nurse, Neuroscience ICU, Saint Luke's Hospital of Kansas City

Read more >